[
    "{\"step_by_step_thinking\": \"Document [0] states that vedolizumab was detectable in ~90% of milk samples collected from all patients. Document [1] also confirms that vedolizumab was measurable in all lactating women who received vedolizumab. Therefore, therapeutic levels of Vedolizumab can be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease.\", \"answer_choice\": \"A\"}"
]